1408PPrognostic factors in non-small cell lung cancer (NSCLC) patients (pts) with brain metastases (BM) treated with immune checkpoint inhibitors (ICI). (23rd October 2018) - Hendriks, L; Henon, C; Auclin, E; Mezquita, L; Ferrara, R; Audigier Valette, C; Mazieres, J; Lefebvre, C; Le Moulec, S; Duchemann, B; Le Pechoux, C; Botticella, A; et al.